NZSE - Delayed Quote NZD

Heartland Group Holdings Limited (HGH.NZ)

Compare
1.0000
-0.0100
(-0.99%)
At close: 4:59:37 PM GMT+13
Loading Chart for HGH.NZ
DELL
  • Previous Close 1.0100
  • Open 1.0100
  • Bid 1.0000 x --
  • Ask 1.0000 x --
  • Day's Range 1.0000 - 1.0250
  • 52 Week Range 0.9400 - 1.4900
  • Volume 459,980
  • Avg. Volume 612,301
  • Market Cap (intraday) 930.561M
  • Beta (5Y Monthly) 1.01
  • PE Ratio (TTM) 10.00
  • EPS (TTM) 0.1000
  • Earnings Date Feb 25, 2025 - Mar 4, 2025
  • Forward Dividend & Yield 0.06 (5.94%)
  • Ex-Dividend Date Sep 5, 2024
  • 1y Target Est 1.26

Heartland Group Holdings Limited, together with its subsidiaries, provides various financial services in New Zealand and Australia. It operates through Motor, Reverse Mortgages, Personal Lending, Business, Rural, and Australian Banking Group segments. The company offers motor vehicle finance; reverse mortgage lending; and transactional, home loans, and personal loans to individuals. It also provides term debt, plant and equipment finance, commercial mortgage lending and working capital solutions for small-to-medium sized business; and specialist financial services, including livestock finance, rural mortgage lending, seasonal and working capital financing, and lending solutions to farming sector. In addition, the company is involved in insurance services; management services; and investment property holding activities. Heartland Group Holdings Limited was founded in 1875 and is based in Auckland, New Zealand.

www.heartlandgroup.info

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: HGH.NZ

View More

Performance Overview: HGH.NZ

Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

HGH.NZ
1.01%
S&P/NZX 50 INDEX GROSS ( GROSS
1.64%

1-Year Return

HGH.NZ
26.71%
S&P/NZX 50 INDEX GROSS ( GROSS
9.66%

3-Year Return

HGH.NZ
53.55%
S&P/NZX 50 INDEX GROSS ( GROSS
0.36%

5-Year Return

HGH.NZ
28.30%
S&P/NZX 50 INDEX GROSS ( GROSS
11.64%

Compare To: HGH.NZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HGH.NZ

View More

Valuation Measures

As of 1/9/2025
  • Market Cap

    939.87M

  • Enterprise Value

    --

  • Trailing P/E

    10.25

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.65

  • Price/Book (mrq)

    0.76

  • Enterprise Value/Revenue

    10.39

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    30.56%

  • Return on Assets (ttm)

    0.88%

  • Return on Equity (ttm)

    6.57%

  • Revenue (ttm)

    243.93M

  • Net Income Avi to Common (ttm)

    74.55M

  • Diluted EPS (ttm)

    0.1000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.31B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: HGH.NZ

View More

People Also Watch